Daymark Wealth Partners, LLC Seagen Inc. Transaction History

Daymark Wealth Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$191.51 - $216.16 $137,504 - $155,202	-718 Reduced 1.12%	63,160 $13.4 Million
Q2 2023 Jul 19, 2023	BUY	$187.64 - $206.25 $2.69 Million - $2.96 Million	14,331 Added 28.92%	63,878 $12.3 Million
Q1 2023 Apr 20, 2023	BUY	$127.59 - $203.08 $6.32 Million - $10.1 Million	49,547 New	49,547 $10 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Daymark Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Daymark Wealth Partners, LLC with notifications on news.